Preview: Life Sciences IP Summit 2016
C5’s Life Sciences IP Summit returns for its third year, offering a comprehensive programme that is bursting with variety, topical relevance and focused discussion on the issues that really matter.
Our summit takes place at a critical time for the industry and there is much to discuss. The UK referendum decision to leave the EU has thrown the Unified Patent Court (UPC) preparations into turmoil and has far-reaching implications for life sciences from practical, regulatory and enforcement perspectives.
Key legislative changes around clinical trials, data privacy and trade secrets provide increased opportunities yet simultaneously greater compliance obligations. Ongoing decisions around second medical use patents remain key to planning cross-jurisdictional strategy.
Join colleagues from across Europe to customise your learning, and network in a prestigious and interactive environment.
Get up to speed with the latest legal and regulatory developments on:
